Jingyuan XuQiaoyun XiaTing WuYong ShaoYatao WangNuyun JinPeiying TianLongyun WuXiaolan Lua Department of Gastroenterology,Shanghai Pudong Hospital,Fudan University Pudong Medical Center,Shanghai,Chinab Department of Gastroenterology,the Affiliated Suzhou Hospital of Nanjing Medical University,Suzhou,Chinac Department of Gastroenterology,The Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an,Chinad Department of Citizen Health,Community Health Service Center of Jinxi Town,Kunshan,China

Abstract:Hepatic immunity is one of the driving forces for the development of nonalcoholic steatohepatitis (NASH), and targeting gut microbiota is believed to affect the hepatic immune constitution. Here, we aimed to investigate the hepatic immunological state in NASH, with a specific emphasis on natural killer (NK) cells. In addition, we aimed to identify the contributing species that target hepatic immunity to provide new directions and support the feasibility of immunotherapy for NASH. A possible NASH population was determined by combination of long-term severe fatty liver, metabolic disorders and increased serum CK18 to detect serum immune factors and gut microbiota. NASH was induced in mice fed a high-fat diet to verify the prophylactic effect of the functional species on the immunopathology and development of NASH. Hepatic immunologic state was examined, and the effector functions of NK cells were detected. Hepatic transcriptome, proteomic, and fecal metagenome were performed. We observed a statistical increase in serum IL-10 (p < 0.001) and non-statistical decrease in interferon-γ and IL-6 in NASH population, hinting at the possibility of immune tolerance. Fecal Bacteroides uniformis and Bifidobacterium bifidum were abundant in healthy population but depleted in NASH patients. In NASH mice, hepatic CD8+T cells, macrophages, and dendritic cells were increased (p < 0.01), and NK cells were inhibited, which were identified with decreased granzyme B (p < 0.05). Bacteroides uniformis and Bifidobacterium bifidum improved hepatic pathological and metabolic cues, increased hepatic NK cells and reduced macrophages (p < 0.05). Bacteroides uniformis also restored hepatic NK cell function, which was identified as increased CD107a (p < 0.05). Transcriptional and translational profiling revealed that the functional species might restore the function of hepatic NK cells through multiple pathways, such as reduction of inhibitory molecules in NK cells. Bacteroides uniformis and Bifidobacterium bifidum are novel prophylactics for NASH that restore the impaired function of hepatic NK cells.

What problem does this paper attempt to address?

The problem this paper attempts to address is whether preventive treatment using specific gut microbiota (such as _Bacteroides uniformis_ and _Bifidobacterium bifidum_) can reverse the immune tolerance of liver natural killer (NK) cells in high-fat diet-induced non-alcoholic steatohepatitis (NASH). Specifically, the researchers focused on the following aspects: 1. **Immune status of NASH patients**: Researchers observed that serum IL-10 levels were significantly elevated in NASH patients, while IFN-γ and IL-6 levels showed no statistical difference, suggesting the presence of immune tolerance. 2. **Changes in gut microbiota**: Through 16S rRNA sequencing, researchers found a significant reduction of _Bacteroides uniformis_ and _Bifidobacterium bifidum_ in the feces of NASH patients. 3. **Validation in mouse models**: In a high-fat diet-induced NASH mouse model, researchers validated the preventive treatment effects of _Bacteroides uniformis_ and _Bifidobacterium bifidum_, finding that these strains could improve liver pathology and metabolic indicators, increase the number of liver NK cells, and reduce macrophages. 4. **Mechanism exploration**: Through transcriptome, proteome, and fecal metagenome analysis, researchers revealed that these strains might restore liver NK cell function through multiple pathways, such as reducing the expression of inhibitory molecules in NK cells. In summary, this study aims to explore the potential therapeutic role of specific gut microbiota in NASH and provide new directions and support for future immunotherapy of NASH.

Prophylactic treatment with Bacteroides uniformis and Bifidobacterium bifidum counteracts hepatic NK cell immune tolerance in nonalcoholic steatohepatitis induced by high fat diet